Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
8 pending office actions • 3 art units • 7 examiners • 0 of 8 (0%) have an AI response strategy ready • 13 patents granted in the last 365 days
Devicor Medical Products Inc. currently manages 8 pending office actions within the Medical Devices & Mechanical Engineering technology area. These matters are distributed across 7 distinct examiners, indicating a broad spread of oversight for the portfolio. The workload spans 3 distinct art units, which suggests some concentration of technical subject matter despite the variety of examiners involved. Practitioners should note that while the 8 pending office actions are relatively spread out, the involvement of 3 distinct art units requires familiarity with specific procedural nuances in those groups.
TOWA, RENE T is identified as the busiest examiner for this company, handling 2 of the pending actions. This specific examiner's workload represents a higher concentration than the average across the 7 distinct examiners. The presence of 7 distinct examiners for only 8 actions means most examiners are handling only one matter each. This distribution may lead to varying prosecution experiences across the portfolio, as many of the 7 distinct examiners are only managing a single pending office action for the company.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (12%) |
| Double-patenting + other | 1 (12%) |
| Multi-statute (no §101) | 6 (75%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TOWA, RENE T | 2 | 49.3% | +17.5% |
| DAVIS, AMELIE R | 1 | 65.0% | +33.4% |
| CATINA, MICHAEL ANTHONY | 1 | 31.5% | +30.3% |
| FRITH, SEAN A | 1 | 62.5% | +26.7% |
| SHOSTAK, ANDREY | 1 | 52.2% | +61.8% |
| COOK, CHRISTOPHER L | 1 | 47.5% | +26.6% |
| CHOI, YOUNHEE JEON | 1 | 71.1% | +49.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19171629 | BIOPSY DEVICE WITH END DEPLOYMENT FOR MARKER DELIVERY | DAVIS, AMELIE R | 36d |
| 18908936 | BIOPSY DEVICE WITH INTEGRATED DITHER FEATURE | CATINA, MICHAEL ANTHONY | — |
| 18908961 | BIOPSY SITE MARKER WITH INCREASED VISUALIZATION AND NON-MIGRATION FEATURES | FRITH, SEAN A | — |
| 18400387 | USER INTERFACE WITH SINGLE INPUT FOR BIOPSY DEVICE | TOWA, RENE T | — |
| 18231921 | BIOPSY SITE MARKER HAVING EXPANDABLE PORTION | CHOI, YOUNHEE JEON | — |
| 17943363 | NON-MIGRATING BIOPSY SITE IDENTIFIERS | TOWA, RENE T | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19171629 | BIOPSY DEVICE WITH END DEPLOYMENT FOR MARKER DELIVERY | DAVIS, AMELIE R | 36d |
| 18908936 | BIOPSY DEVICE WITH INTEGRATED DITHER FEATURE | CATINA, MICHAEL ANTHONY | — |
| 18908961 | BIOPSY SITE MARKER WITH INCREASED VISUALIZATION AND NON-MIGRATION FEATURES | FRITH, SEAN A | — |
| 18647432 | TISSUE SAMPLE HOLDER WITH ENHANCED FEATURES | SHOSTAK, ANDREY | — |
| 18400387 | USER INTERFACE WITH SINGLE INPUT FOR BIOPSY DEVICE | TOWA, RENE T | — |
| 18397048 | BIOPSY SYSTEM FOR USE IN MAGNETIC RESONANCE IMAGING SUITE | COOK, CHRISTOPHER L | — |
| 18231921 | BIOPSY SITE MARKER HAVING EXPANDABLE PORTION | CHOI, YOUNHEE JEON | — |
| 17943363 | NON-MIGRATING BIOPSY SITE IDENTIFIERS | TOWA, RENE T | — |
| Art Unit | Apps |
|---|---|
| 3791 | 3 |
| 3797 | 2 |
| 3798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19171629 | BIOPSY DEVICE WITH END DEPLOYMENT FOR MARKER DELIVERY | DAVIS, AMELIE R | 3798 | §102§103§112 | Non-Final OA | 36d | Pending | Apr 07, 2025 |
| 18908936 | BIOPSY DEVICE WITH INTEGRATED DITHER FEATURE | CATINA, MICHAEL ANTHONY | — | §103§112 | Non-Final OA | — | Pending | Oct 08, 2024 |
| 18908961 | BIOPSY SITE MARKER WITH INCREASED VISUALIZATION AND NON-MIGRATION FEATURES | FRITH, SEAN A | — | §102§103§112 | Non-Final OA | — | Pending | Oct 08, 2024 |
| 18647432 | TISSUE SAMPLE HOLDER WITH ENHANCED FEATURES | SHOSTAK, ANDREY | 3791 | §103§112DP | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18400387 | USER INTERFACE WITH SINGLE INPUT FOR BIOPSY DEVICE | TOWA, RENE T | 3791 | §102§103 | Non-Final OA | — | Pending | Dec 29, 2023 |
| 18397048 | BIOPSY SYSTEM FOR USE IN MAGNETIC RESONANCE IMAGING SUITE | COOK, CHRISTOPHER L | 3797 | §103 | Final Rejection | — | Pending | Dec 27, 2023 |
| 18231921 | BIOPSY SITE MARKER HAVING EXPANDABLE PORTION | CHOI, YOUNHEE JEON | 3797 | §102§103§112 | Non-Final OA | — | Pending | Aug 09, 2023 |
| 17943363 | NON-MIGRATING BIOPSY SITE IDENTIFIERS | TOWA, RENE T | 3791 | §102§103 | Final Rejection | — | Pending | Sep 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial